Form 4 for RCEL AVITA Medical, Inc.

Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071258 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-12-27	2021-12-22	RCEL	Panaccio Lou	Dir	A - Grant	—	+4,350	18.4K	+31%	—
D	2021-12-27	2021-12-22	RCEL	Panaccio Lou	Dir	A - Grant	$0.00	+2,550	2,550	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-22	A	A	4,350	—	18,442	D	—	—	(F1) Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. (F2) Includes 70,460 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above. (F3) Includes unvested RSUs.
2	Derivative	Stock Options (Right to Buy)	2021-12-22	A	A	2,550	$0.00	2,550	D	$12.18 · — to 2031-12-22	2,550 Common Stock	(F6) These Stock Options vest on the date 12 months following the grant date.